Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process.
about
New insights into the role of EMT in tumor immune escape.Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathwayImmune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines.A poxviral-based cancer vaccine the transcription factor twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer modelIL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas.Voltage-gated sodium channel as a target for metastatic risk reduction with re-purposed drugs.Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition.Construction and Immunogenicity Testing of Whole Recombinant Yeast-Based T-Cell Vaccines.Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung CancerCombination therapy with an OX40L fusion protein and a vaccine targeting the transcription factor twist inhibits metastasis in a murine model of breast cancer.M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine.
P2860
Q33869781-85F3D458-5FC2-4949-A3F4-F0E878802CA1Q34444867-15F4BBFC-43E7-4F68-BC30-4D5E2DFB83C6Q34458617-DB6F9D1B-5096-43C6-8ADD-8633219393DBQ36414022-D5348B5E-3A79-448B-AB0E-229843992987Q37085973-8DF1AC38-B953-4A41-8BBD-921BD07BE7D8Q38894913-3EE63E84-5950-41B9-8AF3-2F68AE9EF758Q38953751-36E1EDD5-204A-43D9-A6DA-9F53703EF837Q40801573-0921F62F-BB0D-4C11-B9D3-3AAB12E36A97Q41552614-4177E5AE-07EB-41B2-9953-BB999B48C2CEQ47155705-A55A3DC4-A7C8-4DA5-B364-D890D4410BA2Q55184907-D9D16E7D-4789-4084-BBAF-E66B336BE467
P2860
Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Vaccine-mediated immunotherapy ...... riving the metastatic process.
@ast
Vaccine-mediated immunotherapy ...... riving the metastatic process.
@en
type
label
Vaccine-mediated immunotherapy ...... riving the metastatic process.
@ast
Vaccine-mediated immunotherapy ...... riving the metastatic process.
@en
prefLabel
Vaccine-mediated immunotherapy ...... riving the metastatic process.
@ast
Vaccine-mediated immunotherapy ...... riving the metastatic process.
@en
P2093
P2860
P1433
P1476
Vaccine-mediated immunotherapy ...... driving the metastatic process
@en
P2093
Andressa Ardiani
Anna Kwilas
Claudia Palena
Duane H Hamilton
James W Hodge
Jeffrey Schlom
Thomas H King
P2860
P304
P356
10.1158/0008-5472.CAN-13-2045
P407
P577
2014-02-11T00:00:00Z